Abstract
Metabolism is one of the primary routes of drug elimination from the body. This process comprises of mechanisms, such as oxidation and conjugation, which lead to inactivation and / or elimination from hepatic, biliary, pulmonary, renal and ocular tissues. Enzymes involved in metabolism are expressed in various tissues of the body, liver being the primary site. Studies involving ocular tissues have demonstrated the expression of several metabolic enzymes such as esterases, peptidases, ketone reductases, and CYP-450s in these tissues. These enzymes play an important role in ocular homeostasis by preventing entry and / or eliminating xenobiotics from the ocular tissues. Scientists have targeted these enzymes in drug design and delivery through prodrug derivatization. The prodrugs undergo biotransformation to the parent drug by ocular enzymatic degradation. This review examines the distribution pattern of various metabolic enzymes in the ocular tissues, their physiological role and utility in targeted prodrug delivery.
Keywords: ocular metabolism, cytochrome p-450, drug delivery, detoxification, prodrugs
Current Drug Metabolism
Title: Role of Metabolism in Ocular Drug Delivery
Volume: 5 Issue: 6
Author(s): Sridhar Duvvuri, Soumyajit Majumdar and Ashim K. Mitra
Affiliation:
Keywords: ocular metabolism, cytochrome p-450, drug delivery, detoxification, prodrugs
Abstract: Metabolism is one of the primary routes of drug elimination from the body. This process comprises of mechanisms, such as oxidation and conjugation, which lead to inactivation and / or elimination from hepatic, biliary, pulmonary, renal and ocular tissues. Enzymes involved in metabolism are expressed in various tissues of the body, liver being the primary site. Studies involving ocular tissues have demonstrated the expression of several metabolic enzymes such as esterases, peptidases, ketone reductases, and CYP-450s in these tissues. These enzymes play an important role in ocular homeostasis by preventing entry and / or eliminating xenobiotics from the ocular tissues. Scientists have targeted these enzymes in drug design and delivery through prodrug derivatization. The prodrugs undergo biotransformation to the parent drug by ocular enzymatic degradation. This review examines the distribution pattern of various metabolic enzymes in the ocular tissues, their physiological role and utility in targeted prodrug delivery.
Export Options
About this article
Cite this article as:
Duvvuri Sridhar, Majumdar Soumyajit and Mitra K. Ashim, Role of Metabolism in Ocular Drug Delivery, Current Drug Metabolism 2004; 5 (6) . https://dx.doi.org/10.2174/1389200043335342
DOI https://dx.doi.org/10.2174/1389200043335342 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review of the Physiological Factors Associated with Alcohol Hangover
Current Drug Abuse Reviews The Optimization of HL60-IL6 Assay and its Application in the Pyrogen Detection of Monoclonal Antibody
Current Pharmaceutical Analysis The Influence of Diabetes Mellitus on Proliferation and Osteoblastic Differentiation of MSCs
Current Stem Cell Research & Therapy Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design Synthesis and Antiviral Activity of 2-aryl-4H-chromen-4-one Derivatives Against Chikungunya Virus
Letters in Drug Design & Discovery Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): Still an Obscure Disease
Central Nervous System Agents in Medicinal Chemistry Oral Agents in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neurosarcoidosis
Current Neuropharmacology The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients
Recent Patents on Inflammation & Allergy Drug Discovery Invasive aspergillosis: adjunctive combination therapy
Mini-Reviews in Medicinal Chemistry Influence of Gender on C-Reactive Protein, Fibrinogen, and Erythrocyte Sedimentation Rate in Obstructive Sleep Apnea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Allogenic Mesenchymal Stem Cells as a Treatment for Equine Degenerative Joint Disease: A Pilot Study
Current Stem Cell Research & Therapy A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction
Current Pharmaceutical Design Bioactive Food Components as Dietary Intervention for Cystic Fibrosis
Current Drug Targets The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Current Topics in Medicinal Chemistry New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation
Drug Metabolism Letters Purification of Native and Recombinant Cobra Venom Factor Using Thiophilic Adsorption Chromatography
Protein & Peptide Letters Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction
Current Pharmaceutical Design Osteoblasts and Osteoclasts in Bone Remodeling and Inflammation
Current Drug Targets - Inflammation & Allergy